These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10413501

  • 1. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
    Chen CZ, Shapiro R.
    Biochemistry; 1999 Jul 20; 38(29):9273-85. PubMed ID: 10413501
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.
    Chen CZ, Shapiro R.
    Proc Natl Acad Sci U S A; 1997 Mar 04; 94(5):1761-6. PubMed ID: 9050852
    [Abstract] [Full Text] [Related]

  • 5. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S, Holloway DE, Kumar K, Shapiro R, Acharya KR.
    J Mol Biol; 2005 Apr 01; 347(3):637-55. PubMed ID: 15755456
    [Abstract] [Full Text] [Related]

  • 6. Coulombic forces in protein-RNA interactions: binding and cleavage by ribonuclease A and variants at Lys7, Arg10, and Lys66.
    Fisher BM, Ha JH, Raines RT.
    Biochemistry; 1998 Sep 01; 37(35):12121-32. PubMed ID: 9724524
    [Abstract] [Full Text] [Related]

  • 7. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y, Urrutia M, Smith-Gill SJ, Mariuzza RA.
    Biochemistry; 2003 Jan 14; 42(1):11-22. PubMed ID: 12515535
    [Abstract] [Full Text] [Related]

  • 8. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
    Papageorgiou AC, Shapiro R, Acharya KR.
    EMBO J; 1997 Sep 01; 16(17):5162-77. PubMed ID: 9311977
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Coulombic effects of remote subsites on the active site of ribonuclease A.
    Fisher BM, Schultz LW, Raines RT.
    Biochemistry; 1998 Dec 15; 37(50):17386-401. PubMed ID: 9860854
    [Abstract] [Full Text] [Related]

  • 11. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
    Leonidas DD, Shapiro R, Irons LI, Russo N, Acharya KR.
    Biochemistry; 1999 Aug 10; 38(32):10287-97. PubMed ID: 10441122
    [Abstract] [Full Text] [Related]

  • 12. Selective abolition of pancreatic RNase binding to its inhibitor protein.
    Kumar K, Brady M, Shapiro R.
    Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):53-8. PubMed ID: 14681553
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ, McCoy JG, Bingman CA, Phillips GN, Raines RT.
    J Mol Biol; 2007 Apr 27; 368(2):434-49. PubMed ID: 17350650
    [Abstract] [Full Text] [Related]

  • 14. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
    Jenkins JL, Shapiro R.
    Biochemistry; 2003 Jun 10; 42(22):6674-87. PubMed ID: 12779322
    [Abstract] [Full Text] [Related]

  • 15. Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor. Generation of inhibitor-resistant cytotoxic variants.
    Gaur D, Swaminathan S, Batra JK.
    J Biol Chem; 2001 Jul 06; 276(27):24978-84. PubMed ID: 11342552
    [Abstract] [Full Text] [Related]

  • 16. Tyrosyl interactions in the folding and unfolding of bovine pancreatic ribonuclease A: a study of tyrosine-to-phenylalanine mutants.
    Juminaga D, Wedemeyer WJ, Garduño-Júarez R, McDonald MA, Scheraga HA.
    Biochemistry; 1997 Aug 19; 36(33):10131-45. PubMed ID: 9254610
    [Abstract] [Full Text] [Related]

  • 17. Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41.
    Holloway DE, Chavali GB, Hares MC, Baker MD, Subbarao GV, Shapiro R, Acharya KR.
    Biochemistry; 2004 Feb 10; 43(5):1230-41. PubMed ID: 14756559
    [Abstract] [Full Text] [Related]

  • 18. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
    Cui Q, Sulea T, Schrag JD, Munger C, Hung MN, Naïm M, Cygler M, Purisima EO.
    J Mol Biol; 2008 Jun 13; 379(4):787-802. PubMed ID: 18479705
    [Abstract] [Full Text] [Related]

  • 19. [Anti-oxidative effect of ribonuclease inhibitor by site-directed mutagenesis and expression in Pichia pastoris].
    Wu Y, Zhao BC, Wang JH, Zhao P, Wu YN, Cui XY.
    Yi Chuan; 2005 Mar 13; 27(2):249-54. PubMed ID: 15843355
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor.
    Fu P, Chen J, Tian Y, Watkins T, Cui X, Zhao B.
    Cancer Gene Ther; 2005 Mar 13; 12(3):268-75. PubMed ID: 15592448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.